BioNexus Gene Lab Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioNexus Gene Lab Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • BioNexus Gene Lab Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $233K, a 64.4% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $233K +$91.2K +64.4% Sep 30, 2024 10-Q 2024-11-15
Q2 2024 $242K +$197K +438% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $128K +$76.7K +149% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $142K +$85.8K +154% Dec 31, 2023 10-Q 2024-11-15
Q3 2023 $142K +$117K +467% Sep 30, 2023 10-Q 2024-11-15
Q2 2023 $44.9K +$14.4K +47.2% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 $51.4K +$15.1K +41.5% Mar 31, 2023 10-Q 2023-08-16
Q4 2022 $55.7K +$14.6K +35.6% Dec 31, 2022 10-Q 2024-11-15
Q3 2022 $25K -$19.6K -44% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $30.5K -$20.8K -40.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $36.4K -$19.4K -34.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $41.1K -$21.4K -34.3% Dec 31, 2021 10-K 2024-04-16
Q3 2021 $44.6K +$30.4K +213% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $51.3K +$34.6K +208% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $55.7K +$36.2K +184% Mar 31, 2021 10-Q 2021-05-18
Q4 2020 $62.5K +$39K +166% Dec 31, 2020 10-K 2022-04-06
Q3 2020 $14.3K Sep 30, 2020 10-Q/A 2020-11-09
Q2 2020 $16.6K Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $19.6K Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $23.5K Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.